NCT03283657View on ClinicalTrials.gov

Diabetes Risk Education and Communication Trial

NACompletedINTERVENTIONAL
Enrollment

53

Participants

Timeline

Start Date

November 1, 2017

Primary Completion Date

March 17, 2019

Study Completion Date

March 17, 2019

Conditions
PreDiabetesDiabetes MellitusDiabetes Mellitus, Type 2Body WeightBody Weight Changes
Interventions
BEHAVIORAL

DiRECT

DiRECT participants will meet with a medical assistant (MA) before a routinely scheduled office and formulate a preliminary treatment plan for T2D prevention. Participants will attend their scheduled physician visit, during which they may make a definitive treatment plan to initiate metformin and/or ILI.

BEHAVIORAL

Usual care (UC)

Standard care with routine medical care.

Trial Locations (1)

60611

Northwestern University, Chicago

All Listed Sponsors
collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Northwestern University

OTHER

NCT03283657 - Diabetes Risk Education and Communication Trial | Biotech Hunter | Biotech Hunter